Last update 02 Nov 2024
Aceclidine/Tropicamide
Last update 02 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Tropicamide/aceclidine, PRX 100, PRX-100 |
Target |
Mechanism adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC17H20N2O2 |
InChIKeyBGDKAVGWHJFAGW-UHFFFAOYSA-N |
CAS Registry1508-75-4 |
View All Structures (2)
Related
2
Clinical Trials associated with Aceclidine/TropicamideA Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 (Aceclidine/Tropicamide) Ophthalmic Topical Formulation in the Treatment of Early to Moderate Presbyopia
100 Clinical Results associated with Aceclidine/Tropicamide
Login to view more data
100 Translational Medicine associated with Aceclidine/Tropicamide
Login to view more data
100 Patents (Medical) associated with Aceclidine/Tropicamide
Login to view more data
100 Deals associated with Aceclidine/Tropicamide
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Presbyopia | Phase 2 | US | 01 Sep 2015 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 58 | (Aceclidine+Tropicamide Combination) | lbrgsdbzsk(tatvzzfrru) = kscewajwee lzmvnfveyb (fkhtszducn, bjfybzfrxd - aicwfiialg) View more | - | 19 Apr 2021 | ||
(Aceclidine) | lbrgsdbzsk(tatvzzfrru) = thfnnrhojr lzmvnfveyb (fkhtszducn, prxejndivr - zuqxmvwash) View more | ||||||
NCT03201562 (Biospace) Manual  | Phase 2 | 58 | Aceclidine+Tropicamide | qfdhxlmlvf(aajcgpcrin) = vxkxwnjrlc aatvpwjpnm (pftkygzbwf ) View more | Positive | 30 Jul 2018 | |
Placebo | - |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free